Cancer Immunotherapy with a Serotype 3 Oncolytic Adenovirus

An up to date text book for anyone who is interested in the basics and history of cancer immunotherapy in general and oncolytic viruses in particular. At the time of publication the first oncolytic virus has just been granted by FDA and EMA approval and checkpoint inhibitors are gaining new indications, including melanoma, lung cancer and kidney cancer. By many, immunotherapy is considered as the most important advancement of the 21 century in the field of medicine and cancer. This book gives a thorough overview on the field. The author predicts that all cancers can be controlled by the means of immunotherapy well before he retires. Sit back, read and learn.